person · Reporting owner
Radoff Bradley Louis
Disclosed activity across 11 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BARNWELL INDUSTRIES INCBRN · Entity 7823 | 10% owner | March 28, 2026 | March 31, 2026 |
| HARTE HANKS INCHHS · Entity 7438 | Director | December 09, 2025 | December 11, 2025 |
| KVH INDUSTRIES INC \DE\KVHI · Entity 6612 | 10% owner | May 27, 2026 | May 30, 2026 |
| Lifevantage CorpLFVN · Entity 6941 | See Footnote 1 | August 11, 2023 | August 15, 2023 |
| REGIONAL HEALTH PROPERTIES, INCRHEP · Entity 8343 | 10% owner | April 13, 2026 | August 04, 2026 |
| VAALCO ENERGY INC /DE/EGY · Entity 5308 | Director | November 15, 2021 | November 18, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BARNWELL INDUSTRIES INC
Report date March 28, 2026 · Filed March 31, 2026
Jointly reported with Radoff Family Foundation
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 560,091 |
Reported balance
Holding disclosure · report date 2026-03-28 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 560,091 F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common Stock, $0.50 par valueSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 560,090 |
Reported balance
Holding disclosure · report date 2026-03-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 560,090 F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. |
| Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2029-05-27 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-28 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $1.65 · Expires 2029-05-27 | IndirectBy The Radoff Family Foundation | Not disclosed |
Reported balance
Holding disclosure · report date 2026-03-28 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 3 is filed jointly by Bradley L. Radoff and The Radoff Family Foundation ("Radoff Foundation" and collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, $0.50 par value. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.
HARTE HANKS INC
Report date December 09, 2025 · Filed December 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectRSU shares held by Harte Hanks, granted to the participant but not yet vested | 27,861 |
Reported balance
After 2025-12-09 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-12-09 · Grant · Acquired 27,861 · Balance 27,861 F1: Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | Direct | 391,399 |
Reported balance
Holding disclosure · report date 2025-12-09 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 391,399 |
| Common StockSEC Table I · non-derivative | Direct | 12,048 |
Reported balance
Holding disclosure · report date 2025-12-09 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 12,048 F3: Shares vested 100% on 5/23/2025. |
| Common StockSEC Table I · non-derivative | IndirectCommon stock held in participant's IRA | 20,000 |
Reported balance
Holding disclosure · report date 2025-12-09 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 20,000 F2: Common stock held in participant's IRA |
Filing footnotes · ownership attribution and instrument terms
F1: Participant was granted 27,861 RSU shares on 12/09/2025 that will vest 100% on the first anniversary of the grant date.
F2: Common stock held in participant's IRA
F3: Shares vested 100% on 5/23/2025.
KVH INDUSTRIES INC \DE\
Report date May 27, 2026 · Filed May 30, 2026
Jointly reported with Radoff Family Foundation
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 290,000 |
Last balance in matching sequence
After 2026-05-27 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-05-27 · Sale · Disposed 10,941 · Balance 314,059 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. Row 2 · 2026-05-27 · Sale · Disposed 24,059 · Balance 290,000 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F4: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. |
| Common StockSEC Table I · non-derivative | Direct | 2,180,000 |
Reported balance
Holding disclosure · report date 2026-05-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,180,000 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.
F3: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.7600 to $10.9550, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
F4: Represents a weighted average price. These Shares were sold in multiple transactions at prices ranging from $10.9600 to $11.9600, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
Lifevantage Corp
Report date August 11, 2023 · Filed August 15, 2023
Jointly reported with Radoff Family Foundation
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 50,000 |
Reported balance
After 2023-08-11 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-08-11 · Purchase · Acquired 20,000 · Balance 50,000 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. |
| Common StockSEC Table I · non-derivative | Direct | 811,250 |
Reported balance
Holding disclosure · report date 2023-08-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 811,250 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.
REGIONAL HEALTH PROPERTIES, INC
Report date April 13, 2026 · Filed August 04, 2026
Jointly reported with Radoff Family Foundation
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 220,737 |
Last balance in matching sequence
After 2026-04-22 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2026-04-13 · Purchase · Acquired 6,300 · Balance 215,226 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Row 2 · 2026-04-14 · Purchase · Acquired 3,511 · Balance 218,737 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Row 3 · 2026-04-22 · Purchase · Acquired 2,000 · Balance 220,737 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 105,900 |
Last balance in matching sequence
After 2026-06-15 transaction · row 9
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
6 source rowsRow 4 · 2026-04-13 · Purchase · Acquired 100 · Balance 108,491 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. Row 5 · 2026-04-22 · Purchase · Acquired 500 · Balance 108,991 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. Row 6 · 2026-04-27 · Purchase · Acquired 1,000 · Balance 109,991 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. Row 7 · 2026-04-29 · Purchase · Acquired 1,009 · Balance 111,000 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. Row 8 · 2026-06-05 · Sale · Disposed 5,000 · Balance 106,000 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. Row 9 · 2026-06-15 · Sale · Disposed 100 · Balance 105,900 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation. |
| Series D Preferred StockSEC Table II · derivative / convertible security | Direct | 170,263 |
Reported balance
After 2026-04-14 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-04-14 · Purchase · Acquired 600 · Balance 170,263 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date. |
| Series D Preferred StockSEC Table II · derivative / convertible security | Direct | 171,263 |
Reported balance
After 2026-04-15 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-04-15 · Purchase · Acquired 1,000 · Balance 171,263 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock, no par value (the "Common Stock"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation; however, Mr. Radoff does not have any pecuniary interest in the securities owned by Radoff Foundation.
F3: The Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares (the "Series D Preferred Stock") is convertible at any time at the option of the holder into a number of shares of Common Stock at a conversion ratio equal to 1.1330 shares of Common Stock for every three shares of Series D Preferred Stock, subject to adjustment as provided in the Issuer's articles of amendment. Under the Issuer's articles of amendment, the Series D Preferred Stock may not be converted if, after such conversion, the Reporting Persons would beneficially own, as determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended, more than 19.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such conversion. The Series D Preferred Stock has no expiration date.
VAALCO ENERGY INC /DE/
Report date November 15, 2021 · Filed November 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 1,154,976 |
Ending reported balance
After 2021-11-17 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-11-15 · Sale · Disposed 39,437 · Balance 1,315,539 Row 2 · 2021-11-16 · Sale · Disposed 60,563 · Balance 1,254,976 Row 3 · 2021-11-17 · Sale · Disposed 100,000 · Balance 1,154,976 |
| Common StockSEC Table I · non-derivative | IndirectRadoff Family Foundation | 85,000 |
Reported balance
Holding disclosure · report date 2021-11-15 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 85,000 F1: Shares of common stock beneficially owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the shares of common stock beneficially owned by the Radoff Foundation. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares of common stock beneficially owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the shares of common stock beneficially owned by the Radoff Foundation.
Past disclosures · reporting ended (5)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ENZO BIOCHEM INC
Report date August 20, 2025 · Filed August 20, 2025
Section 16 reporting ended · disclosed 2025-08-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-08-20 transaction · row 1
1 source rowRow 1 · 2025-08-20 · Disposition to issuer · Disposed 4,533,779 · Balance 0 F1: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration"). F2: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes. F3: Represents 142,897 RSUs and 4,390,882 shares of Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 0 |
Reported balance
After 2025-08-20 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2025-08-20 · Disposition to issuer · Disposed 430,000 · Balance 0 F1: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration"). |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were disposed of pursuant to the Agreement and Plan of Merger, dated June 23, 2025 (the "Merger Agreement"), by and among the Issuer, Bethpage Parent, Inc. ("Parent"), and Bethpage Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), was canceled and automatically converted into the right to receive $0.70 in cash, without interest and less any applicable withholding taxes (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit ("RSU") that vested solely on the basis of time that was outstanding as of immediately prior to the Effective Time and was held by a member of the Issuer's Board of Directors was canceled and converted into the right to receive an amount in cash obtained by multiplying (A) the total number of shares of Common Stock underlying such RSU, by (B) the Merger Consideration, subject to any required withholding of taxes.
F3: Represents 142,897 RSUs and 4,390,882 shares of Common Stock.
FARMER BROTHERS CO
Report date May 05, 2026 · Filed May 05, 2026
Section 16 reporting ended · disclosed 2026-05-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-05-05 transaction · row 1
1 source rowRow 1 · 2026-05-05 · Disposition to issuer · Disposed 368,679 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended. |
| Common StockSEC Table I · non-derivative | IndirectBy the Radoff Family Foundation | 0 |
Reported balance
After 2026-05-05 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-05-05 · Disposition to issuer · Disposed 125,000 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated March 3, 2026, by and among the Issuer, Royal Cup, Inc. ("Parent") and BP I Brew Merger Sub Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Parent (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $1.00 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $1.29 per share of Common Stock in cash, without interest. The disposition of the securities by the Reporting Person in the Merger was approved by the Company's board of directors in the manner contemplated by Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
Guardion Health Sciences, Inc.
Report date August 26, 2024 · Filed August 28, 2024
Jointly reported with Radoff Family Foundation
Section 16 reporting ended · disclosed 2024-08-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 112,414 |
Last balance in matching sequence
After 2024-08-26 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2024-08-26 · Sale · Disposed 52,686 · Balance 165,214 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2024-08-26 · Sale · Disposed 44,550 · Balance 120,664 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2024-08-26 · Sale · Disposed 8,250 · Balance 112,414 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 15,046 |
Reported balance
After 2024-08-26 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2024-08-26 · Sale · Disposed 10,054 · Balance 15,046 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.
Rocky Mountain Chocolate Factory, Inc.
Report date October 23, 2024 · Filed October 25, 2024
Jointly reported with Radoff Family Foundation
Section 16 reporting ended · disclosed 2024-10-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 450,148 |
Reported balance
After 2024-10-23 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-10-23 · Sale · Disposed 12,400 · Balance 450,148 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy The Radoff Family Foundation | 299,817 |
Reported balance
Holding disclosure · report date 2024-10-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 299,817 F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F2: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation.
Support.com, Inc.
Report date September 14, 2021 · Filed September 15, 2021
Section 16 reporting ended · disclosed 2021-09-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-09-14 transaction · row 1
1 source rowRow 1 · 2021-09-14 · Disposition to issuer · Disposed 435,536 · Balance 0 F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge. F2: (Continued form Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio"). F3: Represents 410,156 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person. |
| Common StockSEC Table I · non-derivative | IndirectBy BLR Partners, LP | 0 |
Reported balance
After 2021-09-14 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-09-14 · Disposition to issuer · Disposed 1,301,874 · Balance 0 F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge. F2: (Continued form Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio"). |
Filing footnotes · ownership attribution and instrument terms
F1: Support.com, Inc., a Delaware corporation (the "Company"), entered into an Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 19, 2021, by and among the Company, Greenidge Generation Holdings Inc., a Delaware corporation ("Greenidge") and GGH Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Greenidge ("Merger Sub"). On September 14, 2021, Merger Sub merged with and into the Company, the separate corporate existence of Merger Sub ceased and the Company survived the merger as a direct wholly owned subsidiary of Greenidge.
F2: (Continued form Footnote 1) Pursuant to the terms of the Merger Agreement, each share of common stock, par value $0.0001 per share, of the Company (the "Common Stock") and each restricted stock unit of the Company that was outstanding as of the closing of the merger (the "Closing") was converted into the right to receive 0.115 shares of class A common stock, par value $0.0001 per share, of Greenidge (the "Greenidge Class A Common Stock") (the "Exchange Ratio").
F3: Represents 410,156 shares of Common Stock and 25,380 restricted stock units held by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 5,853 | $5.65 | $33,069.45 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 15 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,886 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 200 | $5.65 | $1,130.00 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 14 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,033 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 10,124 | $5.64 | $57,099.36 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 13 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,833 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 100 | $5.64 | $564.00 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 12 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,709 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 330 | $5.63 | $1,857.90 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 11 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,609 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 100 | $5.62 | $562.00 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 10 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,279 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 270 | $5.61 | $1,514.70 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 9 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,179 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 691 | $5.60 | $3,869.60 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 8 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,909 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 711 | $5.60 | $3,981.60 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 7 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 335,218 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 703 | $5.59 | $3,929.77 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 6 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 334,507 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 66 | $5.58 | $368.28 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 5 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,804 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 381 | $5.57 | $2,122.17 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 4 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,738 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 282 | $5.55 | $1,565.10 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 3 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,357 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 1,500 | $5.54 | $8,310.00 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,075 F1 · shares: Participant purchased common shares. Read SEC document |
| December 04, 2024 Filed Dec 5, 2024 23:07 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 176 | $5.50 | $968.00 |
DisclosureSEC source: 0000045919-24-000091 · wk-form4_1733440042.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,575 F1 · shares: Participant purchased common shares. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 16:13 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 32,501 | $4.86 | $157,980.86 |
DisclosureSEC source: 0000921895-24-002606 · form409076051_11132024.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,110,000 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.7800 to $4.9000, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| November 11, 2024 Filed Nov 13, 2024 16:13 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 17,499 | $4.67 | $81,734.33 |
DisclosureSEC source: 0000921895-24-002606 · form409076051_11132024.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,077,499 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.5000 to $4.7000, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 23, 2024 Filed Oct 25, 2024 20:10 UTC | Rocky Mountain Chocolate Factory, Inc. RMCF · Entity 1473 | SaleCommon Stock, $0.001 par value per share | 12,400 | $2.70 | $33,480.00 |
DisclosureSEC source: 0000921895-24-002368 · form409076041_10252024.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,148 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that previously collectively beneficially owned more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 14:17 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 29,912 | $4.63 | $138,570.33 |
DisclosureSEC source: 0000921895-24-002104 · form409076051_09062024.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By The Radoff Family Foundation Disclosed balance after: 325,000 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.6000 to $4.6800, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. Read SEC document |
| September 04, 2024 Filed Sep 6, 2024 14:17 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 30,088 | $4.63 | $139,226.20 |
DisclosureSEC source: 0000921895-24-002104 · form409076051_09062024.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By The Radoff Family Foundation Disclosed balance after: 295,088 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.5600 to $4.6900, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | SaleCommon Stock | 10,054 | $13.80 | $138,734.14 |
DisclosureSEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 4 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By The Radoff Family Foundation Disclosed balance after: 15,046 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.39 to $14.38 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | SaleCommon Stock | 8,250 | $15.77 | $130,102.50 |
DisclosureSEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 3 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,414 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | SaleCommon Stock | 44,550 | $14.46 | $644,193.00 |
DisclosureSEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,664 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.19 to $15.01 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | SaleCommon Stock | 52,686 | $13.54 | $713,389.51 |
DisclosureSEC source: 0000921895-24-001969 · form409076054_08282024.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,214 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons was deemed to be a member of a Section 13(d) group that was previously deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.05 to $13.85 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 17, 2024 Filed Aug 19, 2024 20:58 UTC | HARTE HANKS INC HHS · Entity 7438 | OtherCommon Stock | 16,216 | $7.36 | $119,349.76 |
DisclosureSEC source: 0000045919-24-000071 · wk-form4_1724101127.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,399 F1 · kind: RSU shares vested and converted from indirect owned non-derivatives to direct owned non-derivative shares. Read SEC document |
| August 17, 2024 Filed Aug 19, 2024 20:58 UTC | HARTE HANKS INC HHS · Entity 7438 | OtherCommon Stock | 16,216 | $7.36 | $119,349.76 |
DisclosureSEC source: 0000045919-24-000071 · wk-form4_1724101127.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · RSU shares held by Harte Hanks, granted to participant but not yet vested Disclosed balance after: 0 F1 · kind: RSU shares vested and converted from indirect owned non-derivatives to direct owned non-derivative shares. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 21:29 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 23,900 | $7.29 | $174,283.58 |
DisclosureSEC source: 0000045919-24-000068 · wk-form4_1723757344.xml · nonDerivative · entry 3 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,183 F1 · shares: Participant purchased common shares. Read SEC document |
| August 14, 2024 Filed Aug 15, 2024 21:29 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 11,993 | $7.08 | $84,910.44 |
DisclosureSEC source: 0000045919-24-000068 · wk-form4_1723757344.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,283 F1 · shares: Participant purchased common shares. Read SEC document |
| August 13, 2024 Filed Aug 15, 2024 21:29 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 38,007 | $7.23 | $274,665.19 |
DisclosureSEC source: 0000045919-24-000068 · wk-form4_1723757344.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,290 F1 · shares: Participant purchased common shares. Read SEC document |
| August 05, 2024 Filed Aug 5, 2024 21:15 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 50,500 | $4.50 | $227,143.95 |
DisclosureSEC source: 0000921895-24-001685 · form409076051_08052024.xml · nonDerivative · entry 3 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,060,000 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F5 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.3900 to $4.6400, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 21:15 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 63,159 | $4.53 | $286,350.27 |
DisclosureSEC source: 0000921895-24-001685 · form409076051_08052024.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By The Radoff Family Foundation Disclosed balance after: 265,000 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F4 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.4700 to $4.5700, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. Read SEC document |
| August 01, 2024 Filed Aug 5, 2024 21:15 UTC | KVH INDUSTRIES INC \DE\ KVHI · Entity 6612 | PurchaseCommon Stock | 239,173 | $4.35 | $1,040,665.64 |
DisclosureSEC source: 0000921895-24-001685 · form409076051_08052024.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,009,500 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock (the "Shares"). Each Reporting Person disclaims beneficial ownership of the securities of the Issuer reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3 · price: Represents a weighted average price. These Shares were purchased in multiple transactions at prices ranging from $4.2935 to $4.6100, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| May 29, 2024 Filed May 31, 2024 21:40 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 12,048 | $7.47 | $89,998.56 |
DisclosureSEC source: 0000045919-24-000050 · wk-form4_1717191594.xml · nonDerivative · entry 4 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · RSU shares held by Harte Hanks, granted to the participant but not yet vested Disclosed balance after: 12,048 F3 · balance_after: Participant was granted 12,048 RSU shares on 5/23/2024 that will vest 100% on the first anniversary of the grant date. Read SEC document |
| February 12, 2024 Filed Feb 13, 2024 23:10 UTC | FARMER BROTHERS CO FARM · Entity 49843 | GrantCommon Stock | 25,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-004569 · wk-form4_1707865843.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,679 F1 · kind: Grant of restricted stock units ("RSUs") under the Farmer Bros. Co. 2017 Long-Term Incentive Plan ("Plan") granted on February 12, 2024 ("Grant Date"). Subject to the provisions of the Plan and the RSU grant agreement, the RSUs shall vest 100% on the earlier of: (i) the one year anniversary of the Grant Date or (ii) the date of the first annual meeting of the Company's stockholders immediately following the Grant Date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:00 UTC | ENZO BIOCHEM INC ENZ · Entity 76314 | GrantCommon Stock | 79,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-24-009793 · ownership.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,390,882 F1 · shares: The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., January 31, 2025), or (ii) a change of control event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 16:48 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 20,000 | $7.23 | $144,670.00 |
DisclosureSEC source: 0001437749-23-033463 · rdgdoc.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,997 F1 · shares: Participant purchased common stock. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:24 UTC Amendment | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 20,000 | $7.23 | $144,670.00 |
DisclosureSEC source: 0001437749-23-033683 · rdgdoc.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,283 F2 · shares: Participant purchased common stock. F1 · balance_after: This amount changed from the original Form 4 submission to reflect 216,283 shares directly owned by the reporting person. There are also 36,216 indirect shares owned by the reporting person. Read SEC document |
| November 29, 2023 Filed Nov 29, 2023 23:19 UTC | HARTE HANKS INC HHS · Entity 7438 | PurchaseCommon Stock | 10,000 | $6.82 | $68,197.00 |
DisclosureSEC source: 0001437749-23-033194 · rdgdoc.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,997 F1 · shares: Participant purchased common stock. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 20:54 UTC | FARMER BROTHERS CO FARM · Entity 49843 | PurchaseCommon Stock | 80,000 | $2.58 | $206,248.00 |
DisclosureSEC source: 0001380585-23-000001 · primary_doc.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 304,794 Read SEC document |
| August 17, 2023 Filed Aug 21, 2023 18:54 UTC | HARTE HANKS INC HHS · Entity 7438 | GrantCommon Stock | 16,216 | $5.55 | $89,998.80 |
DisclosureSEC source: 0001437749-23-024263 · rdgdoc.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,997 F1 · shares: On August 17, 2023 the reporting person was granted 16,216 Restricted Stock Units, vesting in full on the first anniversary of the grant date. Read SEC document |
| August 11, 2023 Filed Aug 15, 2023 20:15 UTC | Lifevantage Corp LFVN · Entity 6941 | PurchaseCommon Stock | 20,000 | $5.07 | $101,332.00 |
DisclosureSEC source: 0000921895-23-001976 · form409076057_08152023.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · See Footnote 1 Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By The Radoff Family Foundation Disclosed balance after: 50,000 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each Reporting Person may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by the other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F2 · ownership.nature: Represents securities owned directly by Radoff Foundation. Mr. Radoff, as a director of Radoff Foundation, may be deemed the beneficial owner of the securities owned by Radoff Foundation. Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 21:57 UTC | FARMER BROTHERS CO FARM · Entity 49843 | GrantCommon Stock | 24,794 | $0.00 | $0.00 |
DisclosureSEC source: 0000034563-23-000022 · wf-form4_167632539325097.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,794 F1 · kind: Grant of restricted stock units ("RSUs") under the Farmer Bros. Co. 2017 Long-Term Incentive Plan ("Plan"), granted on February 10, 2023 ("Grant Date"). Subject to the provisions of the Plan and the RSU grant agreement, the RSUs shall vest 100% on the earlier of (i) the one year anniversary of the Grant Date or (ii) the date of the first annual meeting of the Company's stockholders immediately following the Grant Date. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 21:38 UTC | ENZO BIOCHEM INC ENZ · Entity 76314 | GrantCommon Stock, $0.01 Par Value | 75,188 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-23-010982 · ownership.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,311,517 F1 · security: The Reporting Person was granted Restricted Stock Units that will fully vest upon the earlier of: (i) the first anniversary of the grant date (i.e., February 9, 2024), or (ii) a change of control event. Read SEC document |
| January 10, 2023 Filed Jan 11, 2023 22:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | PurchaseCommon Stock | 13,270 | $8.00 | $106,145.40 |
DisclosureSEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 4 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,900 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.97 to $8.00 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Read SEC document |
| January 10, 2023 Filed Jan 11, 2023 22:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | PurchaseCommon Stock | 18,630 | $7.31 | $136,207.66 |
DisclosureSEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 3 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,630 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.75 to $7.70 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 22:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | PurchaseCommon Stock | 20,838 | $7.19 | $149,925.24 |
DisclosureSEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,000 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.05 to $7.48 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 22:11 UTC | Guardion Health Sciences, Inc. GHSI · Entity 87936 | PurchaseCommon Stock | 63,983 | $6.78 | $433,561.60 |
DisclosureSEC source: 0000921895-23-000097 · form409076ghsi_01112023.xml · nonDerivative · entry 1 Radoff Bradley Louis · CIK 0001380585 · 10% owner Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,162 F1 · security: This Form 4 is filed jointly by The Radoff Family Foundation ("Radoff Foundation") and Bradley L. Radoff (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that may be deemed to collectively beneficially own more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.7762 to $7.0417 per share. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote. Read SEC document |
| October 05, 2022 Filed Oct 7, 2022 20:19 UTC | FARMER BROTHERS CO FARM · Entity 49843 | PurchaseCommon Stock | 50,000 | $5.05 | $252,310.00 |
DisclosureSEC source: 0000921895-22-002791 · form408569044_10072022.xml · nonDerivative · entry 2 Radoff Bradley Louis · CIK 0001380585 · See Footnote 1 Radoff Family Foundation · CIK 0001496916 · See Footnote 1 Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By The Radoff Family Foundation Disclosed balance after: 125,000 F1 · security: The Reporting Persons may be deemed to be members of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding Common Stock. Each Reporting Person disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that he or it is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F2 · ownership.nature: Securities owned directly by the Radoff Foundation. As a director of the Radoff Foundation, Mr. Radoff may be deemed to beneficially own the securities owned directly by the Radoff Foundation. Read SEC document |
| August 17, 2022 Filed Aug 17, 2022 21:35 UTC | HARTE HANKS INC HHS · Entity 7438 | SaleCommon stock | 20,000 | $16.31 | $326,168.00 |
DisclosureSEC source: 0000921895-22-002489 · form409076001_08172022.xml · nonDerivative · entry 5 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BLR Partners LP Disclosed balance after: 160,000 F1 · security: The reporting person disclaims beneficial ownership of the securities of the Issuer reported owned herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F6 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.90 to $16.82 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares of common stock beneficially owned directly by BLR Partners LP. Mr. Radoff, as the sole shareholder and sole director of BLRGP Inc., which serves as the general partner of BLRPart LP, which serves as the general partner of BLR Partners LP, and as the sole shareholder and sole director of FLMP Inc., which serves as the general partner of Fondren Management, LP, which serves as the investment manager of BLR Partners LP, may be deemed to beneficially own the shares of Common Stock beneficially owned directly by BLR Partners LP. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 21:35 UTC | HARTE HANKS INC HHS · Entity 7438 | SaleCommon stock | 333,502 | $15.17 | $5,058,324.88 |
DisclosureSEC source: 0000921895-22-002489 · form409076001_08172022.xml · nonDerivative · entry 4 Radoff Bradley Louis · CIK 0001380585 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · BLR Partners LP Disclosed balance after: 180,000 F1 · security: The reporting person disclaims beneficial ownership of the securities of the Issuer reported owned herein except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.755 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · ownership.nature: Shares of common stock beneficially owned directly by BLR Partners LP. Mr. Radoff, as the sole shareholder and sole director of BLRGP Inc., which serves as the general partner of BLRPart LP, which serves as the general partner of BLR Partners LP, and as the sole shareholder and sole director of FLMP Inc., which serves as the general partner of Fondren Management, LP, which serves as the investment manager of BLR Partners LP, may be deemed to beneficially own the shares of Common Stock beneficially owned directly by BLR Partners LP. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.